Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024PR Newswire • 19 days ago
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 PR Newswire...
Share to Feed
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge PR Newswire BOSTON, April 4, 2024...
Haemonetics Corporation Completes Acquisition of Attune Medical Haemonetics Corporation Completes Acquisition of Attune Medical PR Newswire BOSTON, April 1, 2024 BOSTON, April 1, 2024 /PRNewswire...
Haemonetics Co. (NYSE:HAE - Free Report) - Stock analysts at Zacks Research raised their Q1 2025 earnings estimates for shares of Haemonetics in a report issued on Thursday, March 28th. Zacks...
Haemonetics Co. (NYSE:HAE Free Report) Stock analysts at Zacks Research upped their Q1 2025 EPS estimates for Haemonetics in a research note issued on Thursday, March 28th. Zacks...
After reaching an important support level, Haemonetics (HAE) could be a good stock pick from a technical perspective. HAE surpassed resistance at the 200-day moving average, suggesting a long-term...
In trading on Thursday, shares of Haemonetics Corp. (HAE) crossed above their 200 day moving average of 84.80, changing hands as high as 84.82 per share...
This is a signal that HAE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that HAE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that HAE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...